Reduction of gastro-intestinal adverse effect risk in long-term therapy with acetylsalicylic acid
Aim. To study the safety and tolerability of long-term anti-aggregant therapy in patients with coronary heart disease (CHD), comparing enteric-coated acetylsalicylic acid (ASA) and standard ASA forms. Material and methods. The study included 100 CHD patients, with myocardial infarction in anamnesis....
Saved in:
Main Authors: | E. Yu. Bulakhova, O. Yu. Korennova, V. A. Kozyreva, S. D. Kurochkina, S. A. Murotova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2103 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NSAID-induced gastro-duodenal bleeding: risk of development and patient management
by: A P Rebrov, et al.
Published: (2008-04-01) -
Psychosomatic relations in gastro-intestinal diseases in therapeutic practice
by: I. G. Kartashova
Published: (2008-09-01) -
Role of serotonin in physiology and diseases of gastro-intestinal tract
by: E. F. Barinov, et al.
Published: (2012-04-01) -
EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01) -
Clinic immunological comparison when studying erosive affections of gastro duodenal zone in patients with bronchial asthma
by: G. M. Chernyavskaya, et al.
Published: (2003-03-01)